19-44708169-G-C
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_001039213.4(CEACAM16):āc.1249G>Cā(p.Val417Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,576,434 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001039213.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.1249G>C | p.Val417Leu | missense_variant | 6/7 | ENST00000587331.7 | NP_001034302.2 | |
CEACAM16 | XM_017026795.2 | c.1249G>C | p.Val417Leu | missense_variant | 5/5 | XP_016882284.1 | ||
CEACAM16-AS1 | NR_186815.1 | n.348-8992C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM16 | ENST00000587331.7 | c.1249G>C | p.Val417Leu | missense_variant | 6/7 | 1 | NM_001039213.4 | ENSP00000466561.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152260Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000605 AC: 134AN: 221314Hom.: 0 AF XY: 0.000558 AC XY: 67AN XY: 120084
GnomAD4 exome AF: 0.000315 AC: 449AN: 1424174Hom.: 0 Cov.: 34 AF XY: 0.000321 AC XY: 225AN XY: 701314
GnomAD4 genome AF: 0.000315 AC: 48AN: 152260Hom.: 1 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74394
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 27, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 29, 2016 | p.Val417Leu in exon 6 of CEACAM16: This variant is not expected to have clinica l significance due to a lack of conservation across species, including mammals. Of note, 9 mammals have a leucine (Leu) at this position despite high nearby ami no acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. It has been identified in 0.1% (45/ 34408) of European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org; dbSNP rs199597608). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at